INVO Bioscience, Inc. (NASDAQ:INVO) Q2 2023 Earnings Call Transcript
Operator: Good afternoon. And welcome, to the INVO Bioscience Second Quarter Fiscal Year 2023 Financial Results Conference Call. All participants will be in listen-only mode.
Invo Bioscience Inc. (INVO)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Sabby Capital Hal Mintz | 18,624 | $25,142 | -92% | 0.02% |
| 2. | Citadel Investment Group Ken Griffin | 0 | $0 | -100% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.95 | 58,885 | Officer, Director | 128,420 | 2022-06-01 | Filing | |
| $0.95 | 14,474 | Director | 39,175 | 2022-06-01 | Filing | |
| $0.95 | 10,526 | Director | 22,991 | 2022-06-01 | Filing | |
| $0.95 | 11,184 | Director | 33,622 | 2022-06-01 | Filing | |
| $0.95 | 9,211 | Director | 28,220 | 2022-06-01 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.05 | 500,000 | Large Shareholder | 24,694,000 | 2018-12-03 | Filing | |
| $0.19 | 12,642 | Large Shareholder | 25,283,122 | 2018-03-05 | Filing | |
| $0.12 | 1,000 | Large Shareholder | 25,295,764 | 2018-02-21 | Filing | |
| $0.18 | 2,000 | Large Shareholder | 25,296,764 | 2018-02-28 | Filing | |
| $0.18 | 100 | Large Shareholder | 25,298,764 | 2018-02-23 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 54,058 | $72,978 | 0% | |
| 2. | 26,826 | $36,215 | 0% | |
| 3. | 7,155 | $9,659 | 0% | |
| 4. | 4,945 | $6,676 | 0% | |
| 5. | 538 | $1,000 | 0% |
News See All
Billionaire Hedge Funds
